Clinical Trials Logo

Clinical Trial Summary

A three month follow-up study to evaluate the effectiveness of a tailored anti-inflammatory eating plan guided by a registered dietitian to treat irritable bowel syndrome.


Clinical Trial Description

This study will have 60 participants with Irritable bowel syndrome (IBS) for a duration of three months. The procedures will consist of anthropometric measures, blood pressure, questionnaires, and a blood sample. There will be seven visits with one including a virtual meeting with a registered dietitian involved in the Lifestyle Eating and Performance (LEAP) program. With these procedures the investigators will test the effectiveness of the LEAP program for the treatment of irritable bowel syndrome by improving inflammatory markers, symptoms, and quality of life. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05178017
Study type Interventional
Source Oxford Biomedical Technologies, Inc.
Contact Gustavo Zarini, Ph.D., RD
Phone 888-669-5327
Email [email protected]
Status Recruiting
Phase N/A
Start date September 1, 2021
Completion date September 1, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT05118243 - Innovative Tools to Produce Legume-based Foods for Increased Consumer Acceptance N/A
Completed NCT04422327 - The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome Phase 1/Phase 2
Recruiting NCT03131414 - The IMAGINE-SPOR CIHR Chronic Disease Network
Completed NCT03333291 - Fecal Transplantation in Patients With IBS N/A
Active, not recruiting NCT03449628 - L. Casei DG® in Patients With Irritable Bowel Syndrome. N/A
Not yet recruiting NCT05054309 - A Trial to Evaluate the Effects of Bifidobacterium Longum NCC3001 on Intestinal and Psychological Symptoms in Subjects With Irritable Bowel Syndrome N/A
Recruiting NCT04760353 - The Effect of a Probiotic Mixture in Obese Patients With Irritable Bowel Syndrome N/A
Recruiting NCT04217733 - Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome Phase 3
Completed NCT03178877 - The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related Factors N/A
Enrolling by invitation NCT03948854 - Implementing a Low FODMAP Diet in Irritable Bowel Syndrome Patients N/A
Completed NCT04898257 - Effect of Lactibiane Tolerance® to Treat Leaky Gut in Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)Patients N/A
Recruiting NCT04074421 - Effects of Continuous Treatment With Rifaximin and Probiotics on the Gut Microbiota of Patients With IBS-D Phase 4
Completed NCT04348760 - Study of Inflammatory Markers and Symptom Severity in Personalized Nutritional Intervention in IBS N/A
Recruiting NCT03555188 - TReatment of Irritable Bowel Syndrome With Diarrhoea Using Titrated ONdansetron Trial Phase 3
Completed NCT04543474 - Treatment Efficacy of Low FODMAP Versus Low Lactose Diet in IBS Patients N/A
Not yet recruiting NCT05192603 - Comparison Between Low FODMAP and SSRD in IBS N/A
Recruiting NCT04060121 - Efficacy of Psychological Therapies in Patients With Functional Bowel Disorders
Recruiting NCT04129762 - Effect of a Diet Without Non-caloric Sweeteners on Gastrointestinal Symptoms in Patients With IBS and Dyspepsia N/A
Completed NCT04817683 - Study on the Relationship Between Mobile Phone Addiction and Functional Gastrointestinal Disorders
Completed NCT04256551 - Effects of a Novel Machine Learning Mobile App on Diet Adherence in Individuals Following the Low Fodmap Diet N/A